Wilson Sonsini Goodrich & Rosati advised Lilly Asia Ventures on the deal. Regor Therapeutics, a clinical-stage biotechnology company dedicated to the discovery of innovative medicines to...
Regor Therapeutics’ $90 Million Series B Financing
LAV Fund VI and LAV Fund VI Opportunities’ Fundraising
Kirkland advised Lilly Asia Ventures on the deal. Lilly Asia Ventures (LAV) completed the final closing of its sixth USD life sciences funds, LAV Fund VI, L.P. and...